Clinical Trial: 3-Dimensional Mapping System: The PULSTAR II Study

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586176) titled '3-Dimensional Mapping System: The PULSTAR II Study' on May 07.

Brief Summary: ### Study Overview

* Study Name In simple terms, this study involves using a new device to treat a heart condition called "Paroxysmal Atrial Fibrillation."

* Sponsor The study is sponsored by a company called Shanghai Shangyang Medical Technology Co., Ltd.

* Trial Devices

The study will utilize two specialized devices:

1. **Nanosecond Pulsed Electric Field Ablation Device**: This device emits special electrical pulses to treat the heart.

2. **Magnetoelectric Dual-Positioning Petal Pulse Ablation Catheter**: This is a catheter that allows for precise n...